the spinocerebellar ataxias types 2, 3, 6, and 7 (Wells and Warren, 1998).
possibility that the proteolytic pathway in these neurons E6-AP has a unique expression pattern. Due to tissuemight be altered (Cummings et al., 1998). Most proteins specific imprinting, the paternal allele is silenced in ceredestined for degradation undergo covalent conjugation bellar Purkinje cells and hippocampal neurons (Albrecht with multiple ubiquitin molecules in a multistep mechaet al., 1997). Interestingly, maternal E6-AP deficiency nism involving several enzymes (reviewed in Schwartz causes the human genetic disorder Angelman syndrome and Ciechanover, 1999). The first step involves the acti-(AS) . AS is a nondegenerative develvation of ubiquitin by the ubiquitin-activating enzyme opmental disorder characterized by mental retardation, (E1). The activated ubiquitin is then transferred to one speech impairment, hyperactivity, seizures, ataxia, and of many ubiquitin-conjugating enzymes (UBCs or E2).
inappropriate laughter (Williams et al., 1995) . Mice with The E2 subsequently transfers the ubiquitin directly to a maternal deficiency of E6-AP (Ube3a (mϪ/pϩ) ) have phethe target substrate or to a substrate-specific ubiquitin notypes analogous to human AS, including learning defiligase (E3). A lysine in the first ubiquitin moiety then cits, impaired performance on the rotating rod, and inbecomes an acceptor for additional ubiquitin molecules ducible seizures (Jiang et al., 1998) . Despite these in successive reactions, thereby creating a polyubiquitin abnormalities, the deficient animals have no detectable chain. This chain then acts as a molecular flag, targeting developmental nor degenerative histological abnormaliproteins for ATP-dependent hydrolysis by the 26S proties of the brain (Jiang et al., 1998) . Given the role E6-teasome, a multicatalytic proteinase composed of a 20S AP plays in the UPP and its unique expression pattern proteasome functional core and a 19S cap-modulator, especially in Purkinje cells, we reasoned that this mouse also termed PA700 (Coux et al., 1996) . The 19S regulamodel would provide an opportunity to investigate the tory complex is known to activate the catalytic core and effects of a compromised ubiquitin-proteasome pathis believed to be involved in not only the recognition way on the polyglutamine-induced pathology in SCA1 of ubiquitinated proteins but also their unfolding and transgenic mice. presentation to the 20S core (Baumeister et al., 1998;  In this study we examined the role of the ubiquitinGlickman et al., 1999). The unfolding of substrates prior proteasome pathway in SCA1 pathogenesis and demonto hydrolysis may also require the activity of a diverse strate that ataxin-1 is polyubiquitinated and can be declass of highly conserved proteins known as molecular graded by the ubiquitin-proteasome pathway, and that chaperones or heat shock proteins (Lee et al., 1996; a genetic perturbation of the ubiquitin pathway leads Rechsteiner, 1998).
to and less specific proteasome inhibitor, MG132 (CBZsulfoxide (DMSO) control. As described above, overexpression of ataxin-1 leads to its aggregation in HeLa LLLAL) (data not shown). There was no significant differcells; upon extraction, either in solution or in situ, a ence between DMSO-(carrier control) and non-DMSOsignificant amount of the mutant protein is found in the treated cells, confirming that DMSO treatment alone detergent-insoluble fraction of the cell (Skinner et al., does not affect ataxin-1 distribution (67% aggregates 1997). Cell lysates were, therefore, separated into deteruntreated, SEM ϭ 3.6%). Therefore, proteasome inhibigent-insoluble and soluble fractions to investigate the tor treatment led to an increase in both frequency and steady-state levels of the two forms of the protein. Imsize of nuclear aggregates. This enhancement is most munoblots were probed with either ataxin-1 antibody or likely due to the increased nuclear concentration of misa monoclonal antisera to the Xpress-tagged epitope. folded proteins, which are not being properly degraded.
With cell equivalents loaded per lane, it is clear that To show that the ␤-lactone effect on ataxin-1 aggrega-␤-lactone treatment led to a marked accumulation of tion was not caused by a general aggregation of ubiquitithe detergent-insoluble form of ataxin-1, suggesting its nated proteins or an abnormal distribution of the proteadegradation is via the proteasome pathway (Figure 2A We next investigated the ubiquitin-mediated degradation of wild-type and mutant ataxin-1. The in vitrotranslated proteins were incubated for 3 hr with HeLa cell extract in the absence of ubiquitin aldehyde. Following trichloroacetic acid (TCA) precipitation, degradation values were determined. Six independent experiments in cell-free extract show that the ATP-mediated degradation of the wild-type protein is at least three times more efficient than that of mutant [92Q] protein ( Figure  3B ). Although the low values in turnover percentage demonstrate both forms of ataxin-1 are relatively resistant to proteasomal degradation in vitro, the data clearly show that the polyglutamine-expanded protein is considerably more resistant to degradation (p Ͻ 0.0005).
SCA1 Mice Lacking Ube3a Expression Have Fewer Nuclear Aggregates
To evaluate the possible role of the ubiquitin pathway in SCA1, we crossbred B05 mice with the well-characterized animals lacking Ube3a expression. In these experiments, we took advantage of the imprinted expression pattern for Ube3a (preferential silencing of the paternal allele in Purkinje cells). Matings were designed to yield SCA1 mice with a targeted disruption of the maternal Ube3a allele (maternal deficiency for Ube3a (mϪ/pϩ) ). Male analyzed the subcellular localization of ataxin-1 in cerebellar sections from the Ube3a, the B05, and the B05/ and [92Q] were translated in the presence of 35 S-methionine from their respective cDNAs using wheat germUbe3a double-mutant mice at 6.5, 9.5, and 12.5 weeks. By immunohistochemistry, the distribution of endogecoupled transcription-translation extract. The in vitro translated proteins were then incubated with a reaction nous ataxin-1 in the Ube3a (mϪ/pϩ) cerebellum was similar to wild-type (data not shown). In Purkinje cells from 9.5-mixture containing the necessary components for ubiquitin conjugation including HeLa cell extract, ATP, week-old B05 mice, ataxin-1 is primarily concentrated to a single nuclear structure, with some sparse distribution and ubiquitin. This reconstituted cell-free system was sufficient to support conjugation of both wild-type and throughout the nucleus ( Figures 4A, 4C, 4E, and 4G) . In 
Ube3a
(mϪ/pϩ) mice had a 4-to 5-fold reduction in percentage of NI at 6.5 and 9.5 weeks compared to B05 littermates. It is intriguing to note that the NI percentage increased with time: there was a 3-fold difference in NI percentage at 12.5 weeks. These data suggest that the lack of this E3-ubiquitin ligase causes a delay in the appearance of NIs, but that other factors are contributing to their formation. Immunohistochemical analysis using ubiquitin antibody demonstrated that the NI that eventually forms in the Purkinje cells in the doublemutant animals contained ubiquitinated material ( Figure  4H ). Northern blot analysis demonstrated no change in SCA1 transgene expression in the B05/Ube3a (mϪ/pϩ) animals, confirming that the decreased frequency of the NI formation was not due to alterations in transgene expression (data not shown). Furthermore, these changes are not due to genetic background effects, as the percentage of Purkinje cells at 9.5 weeks in B05 mice with a paternal deficiency for Ube3a (mϩ/pϪ) is comparable to that of the B05 littermates containing two wild-type into the molecular layer is not evident in the B05 mice (data not shown). These results indicate that lack of expression of an E3-ubiquitin ligase accelerates the polyuntil ages beyond 12 weeks. glutamine-induced pathology in the SCA1-transgenic We next evaluated the progression of pathology in animals. Moreover, this pathology is not dependent on the double mutant animals at 9.5, 12.5, and 14.5 weeks NI formation. using antibodies to ataxin-1 (11NQ) and calbindin (Figures 7D-7F, respectively) . While the subcellular localization of ataxin-1 was primarily nuclear and concentrated Discussion to the NI in the B05 mice at 14.5 and 35 weeks ( Figures  7B and 7C, respectively) and animal models to investigate the significance of the months ( Figure 7C) . As a control, we examined a B05 ubiquitin-proteasome pathway in the pathogenesis of mouse with a paternal deficiency for Ube3a (mϩ/pϪ) at 9.5 SCA1.
weeks (B, D, F, and H). Sections were stained with anti-ataxin-1 11NQ in (A)-(F) and anti-ubiquitin in (G) and (H). Immunofluorescence confocal microscopy shows sparse nuclear staining with a concentration of ataxin-1 to the NI in B05 Purkinje cells (A). In contrast, ataxin-1 immunoreactivity is much more diffuse throughout the nucleus in Purkinje cells in the B05 animals lacking Ube3a (B). Scale bar is in micrometers. The reduced frequency of nuclear aggregates is readily seen with low magnification of the cerebella. Arrows point to Purkinje cells with NI in (C) and arrowhead points to cytoplasmic vacuole in (E). High magnifications of boxed regions in (C) and (D) are shown in (E) and (F) respectively. Arrows in (F

weeks. The mouse showed Purkinje cell morphology and
Several lines of evidence demonstrate that ataxin-1 is ataxin-1 distribution that was similar to B05 age-matched ubiquitinated and degraded by the ubiquitin-dependent proteasome complex. First, inhibitors of the proteasome littermates containing two wild-type Ube3a
(mϩ/pϩ) alleles other polyglutamine repeat proteins.
The accelerated phenotype in the double-mutant anitransgenic mice ataxin-1 localized predominantly to nuclear aggregates, with limited diffuse nuclear localizamals could, alternatively, be the result of altered turnover of other E6-AP-specific targets. If the levels of these tion. In the B05 transgenic animals lacking Ube3a expression, however, ataxin-1 was diffused throughout the factors changed in the cellular pool, there could be an indirect effect on the polyglutamine-induced degeneraPurkinje cell nucleus and cytoplasm, and found only infrequently in nuclear aggregates. One possible explative pathway. We would then need a better understanding of the pathway leading to neurodegeneration and nation of this accelerated phenotype is that mutant ataxin-1 is more toxic if not properly ubiquitinated, the role these factors might play in SCA1 pathogenesis. Whether the pathological alterations in the double muturned-over, or sequestered to an NI, especially if the capacity of the proteasome system is exceeded. Ideally tants are directly or indirectly associated with mutant ataxin-1 toxicity, we have shown that perturbing this this hypothesis would be well supported by analysis of the relative half-life of mutant ataxin-1 in the B05 and pathway accelerates the SCA1-like phenotype in mice. The significance of this pathway in the SCA1 phenotype B05/Ube3a (mϪ/pϩ) mice. Although immunohistochemistry analysis suggests that the level of ataxin-1 is higher in could be further elucidated by generating transgenic animals that overexpress Ube3a in Purkinje cells and the double-mutant animals (Figure 4) , it remains technically challenging to quantitate the abundance of mutant then crossing these animals with the SCA1 mice.
The reduced frequency of mutant ataxin-1 aggregaataxin-1 in the two animals given that the protein is extremely refractory to solubilization and extraction tion in animals deficient for E6-AP demonstrates that other factors, in addition to the polyglutamine repeat, tecting the nucleus from its toxic effects. In the B05
Immunoblotting and Cell Fractionation
Mouse Breeding and Purkinje Cell Counting To generate B05 mice maternally deficient for Ube3a, female Transfected HeLa cells were isolated and counted. Proteasome inhibitor treatment was performed as described above. Cell equivaUbe3a (Ϫ/ϩ) mice on a mixed background (C57BL/6 and 129/SvEv) were mated with male B05 (Ϫ/ϩ) mice (FVB/N). As controls, the reverse lents were pelleted at 228 ϫ g and lysed in 500 l lysis buffer: 10 mM Tris-HCL, pH 8.0, 1% Triton X-100 and 5ϫ protease inhibitors was performed to generate B05 mice paternally deficient for Ube3a. total (see Figure 5) . A Purkinje cell with any size aggregate was scored as a positive (63ϫ objective). Mean, SEM, and t test (two sample assuming unequal variances) were determined in Microsoft Metal Affinity Protein Purification Excel. As a control, we examined a B05 mouse paternally deficient Cells were transfected, treated with proteasome inhibitor, and for Ube3a (mϩ/pϪ) and found it to have a similar frequency of Purkinje counted as described above. Insoluble material was solubilized by cells with nuclear aggregates compared to B05 littermates at 9.5 vortexing in 500 l Guanidinium buffer: 50 mM NaH 2 PO 4 (pH 8.0), weeks (number of Purkinje cells counted for B05, n ϭ 1, 788; for 10 mM Tris-HCl (pH 8.0), 6 M GuanidiniumϪHCl, 100 mM NaCl. DNA B05/Ube3a
(mϩ/pϪ)
, n ϭ 912). was sheared by brief sonication. Any nonsolubilized material was cleared by 15 min centrifugation at 13,000 ϫ g at 4ЊC. The superna
